GB Sciences Inc (GBLX)

0.08
0.00 2.34
OTC
Prev Close 0.08
Open 0.08
Day Low/High 0.07 / 0.08
52 Wk Low/High 0.07 / 0.35
Volume 411.59K
Exchange OTC
Shares Outstanding 252.88B
Market Cap 21.22M
Div & Yield N.A. (N.A)

Latest News

GB Sciences Names Darin Carpenter As Executive Vice President Of Cannabis Operations

GB Sciences Names Darin Carpenter As Executive Vice President Of Cannabis Operations

LAS VEGAS, Aug. 28, 2019 /PRNewswire/ -- GB Sciences, Inc.

GB Sciences Prepares To Launch New Products In Louisiana With Educational Seminars For Doctors And Pharmacists

GB Sciences Prepares To Launch New Products In Louisiana With Educational Seminars For Doctors And Pharmacists

Education program includes evidence-based review of FDA-registered human clinical trial data supporting the use of cannabis to treat approved medical conditions.

GB Sciences Files Novel Patent Application For Chronic Pain Treatments Based On Proprietary Cannabis-Derived Formulations

GB Sciences Files Novel Patent Application For Chronic Pain Treatments Based On Proprietary Cannabis-Derived Formulations

In the US, chronic pain represents an estimated health burden of between $560 and $650 billion dollars.

GB Sciences Obtains Exclusive License For Patented Oral Thin Film Technology Containing Cannabis And Hemp-Derived Ingredients

GB Sciences Obtains Exclusive License For Patented Oral Thin Film Technology Containing Cannabis And Hemp-Derived Ingredients

Oral thin films provide a convenient and accurate delivery system with increased bioavailability of cannabis active ingredients for patients LAS VEGAS, June 11, 2019 /PRNewswire/ -- GB Sciences, Inc.

GBS Global Biopharma And National Research Council Of Canada Begin Preclinical Studies On Chronic-Neuropathic Pain Therapies

GBS Global Biopharma And National Research Council Of Canada Begin Preclinical Studies On Chronic-Neuropathic Pain Therapies

GBS Global Biopharma's proprietary neuropathic pain therapies are orally-delivered, time-released nanoparticles containing myrcene and other cannabinoid-based ingredients

GB Sciences Prepares To Triple Production Capabilities In Its Las Vegas Facility

GB Sciences Prepares To Triple Production Capabilities In Its Las Vegas Facility

Positioned to Increase Revenue by Approximately $5.6 Million

How Disney Wins Even When It Loses; Pot Stocks Pile Into Fundraisings -- ICYMI

How Disney Wins Even When It Loses; Pot Stocks Pile Into Fundraisings -- ICYMI

Here's what you need to know now for Sept. 24.

Pot Is on the Ballot in Election 2016, but Investors Should Proceed With Caution

Pot Is on the Ballot in Election 2016, but Investors Should Proceed With Caution

Marijuana is on the ballot in several states this election cycle, and its approval could be a boon for those in the business -- though obstacles remain.

Making the Right Budding Investment: Medical Versus Recreational Cannabis Companies

Making the Right Budding Investment: Medical Versus Recreational Cannabis Companies

Investors choosing among the hundreds of cannabis businesses are often caught in a conundrum as to whether medical companies are a safer investment compared to recreational businesses.

Cannabis Companies Hunt for Financing, Growth

Cannabis Companies Hunt for Financing, Growth

Companies in the cannabis business have an appetite for capital to fuel what has emerged as one of the largest growth sectors, and more investors are taking the risk.

GrowBLOX Announces Deployment Of Commercial Units

GrowBLOX Announces Deployment Of Commercial Units

Cannabis Cultivation Technology Arrives in Puerto Rico & Nevada

Growblox Sciences Announces Launch Of New Corporate Website

Growblox Sciences Announces Launch Of New Corporate Website

New Corporate Web Presence Showcases Three Operating Divisions